{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:40:33Z","timestamp":1790052033890,"version":"4.0.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T00:00:00Z","timestamp":1426204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0120071","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T18:06:32Z","timestamp":1426269992000},"page":"e0120071","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Decreased Peritoneal Ovarian Cancer Growth in Mice Lacking Expression of Lipid Phosphate Phosphohydrolase 1"],"prefix":"10.1371","volume":"10","author":[{"given":"John","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Raines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill K.","family":"Slack-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/sj.onc.1209261","article-title":"The G12\/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration","volume":"25","author":"D Bian","year":"2006","journal-title":"Oncogene"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2000.tb06550.x","article-title":"Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer","volume":"905","author":"X Fang","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 1","key":"ref3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/bj3520135","article-title":"Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase","volume":"352","author":"X Fang","year":"2000","journal-title":"Biochem J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1947601911419362","article-title":"Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene Galpha(12)","volume":"2","author":"ZG Goldsmith","year":"2011","journal-title":"Genes Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"GB Mills","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref6","first-page":"1223","article-title":"Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients","volume":"1","author":"Y Xu","year":"1995","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1158\/0008-5472.CAN-04-0060","article-title":"Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway","volume":"64","author":"D Bian","year":"2004","journal-title":"Cancer Res"},{"key":"ref8","first-page":"3194","article-title":"Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells","volume":"61","author":"DA Fishman","year":"2001","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"10564","DOI":"10.1074\/jbc.M412152200","article-title":"Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells","volume":"280","author":"H Li","year":"2005","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ygyno.2004.08.001","article-title":"Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8","volume":"95","author":"J So","year":"2004","journal-title":"Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/jnci\/djn378","article-title":"Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells","volume":"100","author":"S Yu","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-6980(01)00110-1","article-title":"Lysophosphatidic acid synthesis and release","volume":"64","author":"C Pages","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","article-title":"Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells","volume":"66","author":"J Ren","year":"2006","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/abio.2001.5000","article-title":"Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids","volume":"290","author":"YJ Xiao","year":"2001","journal-title":"Anal Biochem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1055-9965.1185.13.7","article-title":"Lysophospholipids are potential biomarkers of ovarian cancer","volume":"13","author":"R Sutphen","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1096\/fj.12-207597","article-title":"Elevated and secreted phospholipase A(2) activities as new potential therapeutic targets in human epithelial ovarian cancer","volume":"26","author":"Q Cai","year":"2012","journal-title":"FASEB J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.lfs.2006.12.041","article-title":"Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity","volume":"80","author":"A Tokumura","year":"2007","journal-title":"Life Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/1541-7786.MCR-07-0143","article-title":"Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells","volume":"6","author":"MM Ptaszynska","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref19","first-page":"1073","article-title":"The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer","volume":"63","author":"JL Tanyi","year":"2003","journal-title":"Cancer Res"},{"key":"ref20","first-page":"3534","article-title":"Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer","volume":"9","author":"JL Tanyi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-05-4381","article-title":"Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo","volume":"66","author":"KS Kim","year":"2006","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1535-7163.MCT-08-1106","article-title":"Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis\/metastasis of mouse ovarian cancer in immunocompetent mice","volume":"8","author":"H Li","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BJ20081888","article-title":"Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo","volume":"419","author":"JL Tomsig","year":"2009","journal-title":"Biochem J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"KF Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref25","first-page":"5209","article-title":"Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors","volume":"59","author":"M Prewett","year":"1999","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1158\/0008-5472.CAN-08-2678","article-title":"Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis","volume":"69","author":"JK Slack-Davis","year":"2009","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1242\/dev.00635","article-title":"The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning","volume":"130","author":"D Escalante-Alcalde","year":"2003","journal-title":"Development"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"JA Joyce","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.1302831","article-title":"The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation","volume":"192","author":"S Knowlden","year":"2014","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1172\/JCI1002","article-title":"Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway","volume":"102","author":"JS Koh","year":"1998","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.20071243","article-title":"iPLA2beta: front and center in human monocyte chemotaxis to MCP-1","volume":"205","author":"RS Mishra","year":"2008","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.4049\/jimmunol.1201604","article-title":"Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells","volume":"189","author":"Y Zhang","year":"2012","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/intimm\/dxp035","article-title":"Lysophosphatidic acid inhibits the cytotoxic activity of NK cells: involvement of Gs protein-mediated signaling","volume":"21","author":"M Lagadari","year":"2009","journal-title":"Int Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2326-6066.CIR-13-0043-T","article-title":"Lysophosphatidic Acid Inhibits Cd8 T Cell Activation and Control of Tumor Progression","volume":"1","author":"SK Oda","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1194\/jlr.R800055-JLR200","article-title":"Lipid phosphate phosphatases and signaling","volume":"50","author":"DN Brindley","year":"2009","journal-title":"J Lipid Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0014-5793(99)01400-3","article-title":"Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells","volume":"460","author":"G Hong","year":"1999","journal-title":"FEBS Lett"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0120071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T19:52:34Z","timestamp":1691524354000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0120071"}},"subtitle":[],"editor":[{"given":"Tanya V.","family":"Kalin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,13]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0120071","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,13]]}}}